INCYTE CORP (INCY:NASDAQ)
$118.87 1.2 (1.0198%)
Analysed INCYTE CORP (INCY:NASDAQ) News Sources
Halozyme Announces Global Collaboration and License Agreement with Incyte to Support the Development of Subcutaneous Formulations of INCA033989 Using its ENHANZE® Technology
20-07-2026
yahoo.com
Halozyme Signs ENHANZE Collaboration with Incyte for Subcutaneous INCA033989 Development
20-07-2026
advfn.com
Incyte (INCY) Reports Next Week: Wall Street Expects Earnings Growth
21-07-2026
yahoo.com
HALO Inks Deal With INCY to Support Cancer Therapy Development
21-07-2026
yahoo.com
Earnings Preview: LENZ Therapeutics, Inc. (LENZ) Q2 Earnings Expected to Decline
22-07-2026
yahoo.com
Incyte Gears Up to Report Q2 Earnings: Is a Beat Around the Corner?
24-07-2026
yahoo.com
Incyte (INCY) Reports Full Latarcibart Data And Buys Vega Therapeutics
26-07-2026
yahoo.com
What To Expect From Incyte’s (INCY) Q2 Earnings
27-07-2026
yahoo.com
Incyte Reports Second Quarter 2026 Financial Results and Provides Business Updates
28-07-2026
yahoo.com
Incyte (NASDAQ:INCY) Posts Better-Than-Expected Sales In Q2 CY2026 But Full-Year Sales Guidance Misses Expectations Significantly
28-07-2026
yahoo.com
What is the current price of INCYTE CORP (INCY:NASDAQ)?
The current price of INCYTE CORP (INCY:NASDAQ) is $118.87.
INCYTE CORP (INCY:NASDAQ) absolute price change since previous trading day?
The absolute price change of INCYTE CORP (INCY:NASDAQ) since the previous trading day is $1.2.
INCYTE CORP (INCY:NASDAQ) percentage price change since previous trading day?
The percentage price change of INCYTE CORP (INCY:NASDAQ) since the previous trading day is 1.0198%.
What is the most recent average sentiment score for INCYTE CORP (INCY:NASDAQ)?
The most recent average sentiment score for INCYTE CORP (INCY:NASDAQ) is 57 out of 100.
What is the most recent average sentiment for INCYTE CORP (INCY:NASDAQ)?
The most recent sentiment for INCYTE CORP (INCY:NASDAQ) is .
SEC-8K** Filing Available For INCYTE CORP (INCY:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.